Sinofn Health
Sinofn Health
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences. Established in 2025, we operate from Shanghai as the trading hub for global partners seeking premium, science-driven contract manufacturing services.
Founder Vision: Mrs. GuoHong Liu established SINOFN with a mission to bridge the gap in clinical nutrition. Her commitment to PKU (Phenylketonuria) research evolved into a broader nutraceutical empire, ensuring that our ODM/OEM services are rooted in medical-grade rigorousness.
China holds the world's most robust raw material supply chain for vitamins and herbal extracts. Being proximal to these sources, SINOFN reduces lead times and ensures price stability for our global partners.
Backed by the Chinese Academy of Sciences, our R&D focus is on bioavailability. We don't just "blend" powder; we optimize delivery systems, granulation, and micro-encapsulation to ensure efficacy.
From a 500-unit pilot run to million-unit annual production, our facility is equipped with ISO 22000, HACCP, and FSSC 22000 certifications, meeting stringent international regulatory standards.
Modern consumers are moving away from generic multivitamins. The demand is shifting toward Customized Powdered Formulations. Whether it’s targeted weight management (like our SHAPING MASTER™ line) or specific medical-purpose foods (FSMP), our facility is designed for rapid customization. We provide solutions that allow brands to pivot quickly to market trends without heavy capital expenditure.
Transparency is the new currency. Our extraction technologies, such as the cAMP (Cyclic Adenosine Monophosphate) processes, represent the vanguard of "natural wellness." By leveraging scientific extraction, we ensure that every gram of our powdered supplements delivers maximum nutritional density.
Medical Innovation Director, PhD Peking University Medical School. 15+ years in metabolic disorder formulations.
R&D Lead, CAS Postdoc. Specialist in bioactive compound delivery systems and molecular stabilization.
Formulation Director (Netherlands). Senior Scientist focusing on EU regulatory standards and clean-label tech.
A: We offer flexible MOQs (Minimum Order Quantities) and pilot-scale prototyping. We understand that brands need to test market reactions; therefore, we provide stable, lab-grade batches before full-scale commercialization.
A: Powdered forms (solid drinks) offer superior stability and higher dosage capacity compared to capsules. Our advanced granulation ensures rapid dissolution and better flavor profiles.
A: Our R&D team and regulatory specialists monitor global standards (FDA, EFSA, TGA). Our documentation package includes full CoA (Certificate of Analysis) and stability data required for international registration.
